Plain-language summary
Pilot clinical trial in adults with disordered glucose handling, randomizing participants to carnosine versus placebo. The carnosine arm showed improved insulin sensitivity readouts, providing early human validation for the preclinical metabolic story.
Key takeaways
- ›Insulin sensitivity moved in the right direction.
- ›Tolerability was favorable across the cohort.
- ›Sets up a larger phase-II metabolic program.
About this summary
The summary and key takeaways above are written by our editorial team in plain language for general readers. They are not the original abstract. For the authors' own wording, methodology, statistics, and full reference list, follow the source link to the published record.